Teijin Limited

Equities

3401

JP3544000007

Textiles & Leather Goods

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
1,516 JPY +0.03% Intraday chart for Teijin Limited +2.26% +13.43%

Teijin : Pharma Launches Patient-information Sharing System for Integrated Community-care Support Businesses

November 09, 2015 at 08:36 pm EST

Tokyo, Japan, November 10, 2015 --- Teijin Pharma Limited , the core company of the Teijin Group's medical and pharmaceutical business, announced the launch of the VitalLinkpatient-information sharing system for use in integrated community-care support businesses on September 28.

VitalLinkwill be used to share patients' healthcare information such as body temperature, pulse, blood pressure and blood-oxygen saturation levels-in real time with doctors, care coordinators and other professionals via their mobile devices. VitalLinkenables patients to directly optimize their home healthcare through fast detection of and response to health issues.

Teijin Pharma will market VitalLinkto local governments, municipalities and medical associations that are involved with integrated community-care businesses. The company expects to leverage the VitalLinknetwork to expand its business related to integrated community care, including through the provision of medical equipment. Teijin Pharma is targeting sales of more than 10 billion JPY in this field by 2024.

The new IT-supported healthcare service is one of many forward-looking initiatives under Teijin's Transformation and Growth Strategies for sustainable long-term corporate growth.

The main functions of VitalLink, which was developed by NTT Electronics Corporation , follow.

Communication notebook (SNS)
Enables patients to share information, such as medication counseling, photos and healthcare logs, in real time with healthcare professionals

Vital data sharing
Enables patients to gather and share vital data collected from networked thermometers, sphygmomanometers and pulse oximeters

Dosing information Management
Manages patients' dosing information based on the latest data of Ministry of Health, Labour and Welfare

Calendar
Enables doctors, care coordinators and other healthcare professionals to schedule patient care systematically

In the age of greying societies, integrated community-care support businesses can enable people who require nursing care to continue living in their homes by providing them with access to services for healthcare, nursing, prevention and livelihood support. Patient-information sharing systems also can play an indispensable role in integrated community care by enabling doctors and other professionals to collaborate in the provision of healthcare services.

Teijin Group, under its Transformation and Growth Strategies plan, is integrating key capabilities among its diverse businesses in the healthcare and IT fields. The Home Healthcare ICT Promotion Department, established by Teijin Pharma in October 2014, is now actively identifying and developing business opportunities in the field of integrated community care.

About the Teijin Group
Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of sustainable transportation, information and electronics, safety and protection, environment and energy, and healthcare. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT. The group has some 150 companies and around 16,000 employees spread out over 20 countries worldwide. It posted consolidated sales of JPY786.2 billion (USD 6.6 billion) and total assets of JPY 823.7 billion (USD 6.9 billion) in the fiscal year ending March 31, 2015.

Press Contact
Corporate Communications
Teijin Limited
+81 3 3506 4055
pr@teijin.co.jp

Information in the press releases is current on the date of the announcement.
It is subject to change without prior notice.

Back to 2015 News

Back to Healthcare

Page Top

distributed by

© Publicnow - 2015
Teijin Swings to Fiscal Q1-Q3 Profit MT
Transcript : Teijin Limited, Q3 2024 Earnings Call, Feb 08, 2024
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024 CI
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024 CI
Garwood Medical Devices, LLC announced that it has received funding from Teijin Limited, Pegasus Tech Ventures, Inc. CI
Ascendis Pharma A/S Announces Strategic Partnership with Teijin Limited in Japan CI
Transcript : Teijin Limited, Q2 2024 Earnings Call, Nov 06, 2023
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024 CI
Japan stocks retreat from 33-year peak ahead of Fed policy decision RE
Japan stocks retreat from 33-year peak ahead of Fed policy decision RE
Tipcomposite Co.,Ltd. signed a share transfer agreement to acquire a 99.1% stake in GH Craft Ltd. from Teijin Limited CI
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024 CI
Teijin Limited Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Teijin Limited Provides Dividend Guidance for the End of Second Quarter of Full Year Ending March 31, 2024 CI
Transcript : Teijin Limited, Q1 2024 Earnings Call, Aug 07, 2023
Teijin to Issue Restricted Stock as Remuneration MT
Teijin Limited Approves the Election of Noboru Yamanishi and Tamie Minami as Directors CI
Teijin Establishes New Subsidiary via Company Split MT
Teijin Announces Establishment of A Subsidiary by Company Split CI
Teijin Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Transcript : Teijin Limited, 2023 Earnings Call, May 11, 2023
Teijin Limited Announces Dividend for the Fourth Quarter of Fiscal Year Ended 2022 CI
Teijin Limited Provides Dividend Guidance for the Fiscal Year 2023 CI
Teijin Limited Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Teijin Limited Provides Dividend Guidance for the Second Quarter of 2023 CI
Chart Teijin Limited
More charts
Teijin Limited is a diversified group organized around 5 areas of activity: - manufacturing and distribution of textile products and clothes (37.6% of net sales): textile fibers, polyesters, polymers, etc.; - production of synthetic fibers (35.5%): aramid, carbon and polyester fibers for industrial applications; - manufacturing of care and health products (17.8%): medicines (for the treatment of metabolic, cardiovascular, bone, joint and respiratory diseases), and home care equipments (home oxygen therapy equipments and positive pressure fans); - sale of IT products and services (6.9%); - other (2.2%). Net sales break down geographically as follows: Japan (58.6%), China (13.1%), Asia (6.9%), Americas (13.7%) and other (7.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
1,516 JPY
Average target price
1,340 JPY
Spread / Average Target
-11.61%
Consensus
  1. Stock Market
  2. Equities
  3. 3401 Stock
  4. News Teijin Limited
  5. Teijin : Pharma Launches Patient-information Sharing System for Integrated Community-care Support Businesses